AU1294195A - Compositions and methods for the treatment of dry eyes and other ocular disorders - Google Patents

Compositions and methods for the treatment of dry eyes and other ocular disorders

Info

Publication number
AU1294195A
AU1294195A AU12941/95A AU1294195A AU1294195A AU 1294195 A AU1294195 A AU 1294195A AU 12941/95 A AU12941/95 A AU 12941/95A AU 1294195 A AU1294195 A AU 1294195A AU 1294195 A AU1294195 A AU 1294195A
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
ocular disorders
dry eyes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12941/95A
Inventor
Gregory S Hageman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ocutech Inc
Original Assignee
Ocutech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ocutech Inc filed Critical Ocutech Inc
Publication of AU1294195A publication Critical patent/AU1294195A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
AU12941/95A 1993-11-24 1994-11-23 Compositions and methods for the treatment of dry eyes and other ocular disorders Abandoned AU1294195A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15756093A 1993-11-24 1993-11-24
PCT/US1994/013582 WO1995014488A1 (en) 1993-11-24 1994-11-23 Compositions and methods for the treatment of dry eyes and other ocular disorders
US157560 1999-10-04

Publications (1)

Publication Number Publication Date
AU1294195A true AU1294195A (en) 1995-06-13

Family

ID=22564272

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12941/95A Abandoned AU1294195A (en) 1993-11-24 1994-11-23 Compositions and methods for the treatment of dry eyes and other ocular disorders

Country Status (2)

Country Link
AU (1) AU1294195A (en)
WO (1) WO1995014488A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120005A (en) * 1997-01-14 2000-08-31 Ramot University Authority Of Pharmaceutical compositions for the treatment of the eye

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
US5238920A (en) * 1989-08-22 1993-08-24 Abbott Laboratories Pulmonary surfactant protein fragments
AU655919B2 (en) * 1990-02-22 1995-01-19 Macnaught Pty Limited Artificial tears
GB9021080D0 (en) * 1990-09-26 1990-11-07 Univ Western Ontario Lipid extract surfactant and method of producing same

Also Published As

Publication number Publication date
WO1995014488A1 (en) 1995-06-01

Similar Documents

Publication Publication Date Title
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU8060394A (en) Ophthalmic formulation useful in the treatment of dry eye syndrom
AU6905391A (en) Methods and compositions for the treatment of hodgkin's disease
AU1173195A (en) Treatment of immunoregulatory disorders
EP0820467A4 (en) Methods of treating disorders of the eye
AU2821295A (en) Compositions and methods for the treatment of tumors
AU3965497A (en) Methods of treatment of eye trauma and disorders
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AUPN104895A0 (en) Methods of and preparations for the treatment of ailments and disorders
AU5261898A (en) Tgfalpha for the treatment of ocular hypertension and glaucoma
HU9502623D0 (en) Use of substituted alkyl-nitrates for the treatment of pathologically increased intraocular pressure
AU5699396A (en) Compositions for the treatment of skin conditions
AU4031193A (en) Method and means for preventing constriction of the pupil in the eye
AU5430894A (en) Diagnosis of eye disorders
AU1294195A (en) Compositions and methods for the treatment of dry eyes and other ocular disorders
AU5446798A (en) Compositions and methods for the treatment of gastrointestinal disorders
AU6678194A (en) Agents for the prevention and treatment of huntington's disease and other neurological disorders
AU5293293A (en) Methods and compositions for treatment of allergic disease
AU6581294A (en) Ethanolamine derivatives useful for the treatment of gastrointestinal disorders
AU6979594A (en) Compositions and methods for treatment and prevention of retinal dysfunctions
AU6662794A (en) Composition for the treatment of impaired hair growth
AU3722593A (en) Compositions for the treatment of glaucoma
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
AU1966988A (en) Ophthalmic agent and related compositions and method for treatment of the cornea
AU6295094A (en) Compositions for the treatment of eye diseases